Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of Amivantamab, Lazertinib, and Pemetrexed for Patients with Advanced or Metastatic Solid Tumors, Including EGFR-Mutated Non-Small Cell Lung Cancer
Recruiting
Investigated Diseases:Investigated Drugs:
Study on the Safety and Effectiveness of Nivolumab, Pembrolizumab, and Cemiplimab with Radiotherapy for Stage IV Non-Small Cell Lung Cancer Patients
Recruiting
Investigated Diseases:Investigated Drugs:
Study on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation
Recruiting
Investigated Diseases:Investigated Drugs:
Study on Durvalumab with Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer Patients
Recruiting
Investigated Diseases:Investigated Drugs:
Study of RMC-6291 and Pembrolizumab with or without Chemotherapy for Patients with Advanced KRAS G12C Mutated Lung Cancer
Recruiting
Investigated Diseases:Investigated Drugs:
Study on Preoperative Treatment with Amivantamab, Carboplatin, and Pemetrexed for Patients with Resectable Non-Small-Cell Lung Cancer with EGFR Mutations
Recruiting
Investigated Diseases:Investigated Drugs:
Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels
Recruiting
Investigated Diseases:Investigated Drugs:
+1
Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers
Recruiting
Investigated Diseases:Investigated Drugs:
Study of RMC-6236 and Pembrolizumab with or without Chemotherapy for Patients with RAS-Mutated Non-Small Cell Lung Cancer
Recruiting
Investigated Diseases:Investigated Drugs: